Laparoscopic radical prostatectomy after neoadjuvant hormonal therapy: An apparently safe and effective procedure

Journal of Laparoendoscopic and Advanced Surgical Techniques - Part A

Volumn 14, Issue 6, 2004, Pages 335-338

  Brown, James A ^b   Garlitz, Christopher ^a   Strup, Stephen E ^c   Hubosky, Scott G ^a   Gomella, Leonard ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICALUTAMIDE; CREATININE; FLUTAMIDE; HEMOGLOBIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; EXTRAVASATION; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OPERATION DURATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SAFETY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR BIOPSY;

EID: 10844265342     PISSN: 10926429     EISSN: None     Source Type: Journal    
DOI: 10.1089/lap.2004.14.335     Document Type: Article

References (13)

1. Fair WR, Cookson MS, Stroumbakis N, et al. The indications, rationale, and results of neoadjuvant androgen deprivation and the treatment of prostate cancer: Memorial Sloan-Kettering Cancer Center results. Urology 1997; 49(Suppl 3):S46-S55.
2. Scolieri NJ, Altman A, Resnick MI. Neoadjuvant hormonal ablative therapy before radical prostatectomy: is it indicated? A review. J Urol 2000;164:1465-1472.
3. Schulman CC, Debruyne FM, Forster G, et al. Four-year follow-up results of a European perspective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer: European study group on neoadjuvant treatment of prostate cancer. Eur Urol 2000;38:706-713.
4. Civantos F, Sadek S, Obek C, Lai S, Soloway M. Neoadjuvant hormonal therapy prior to radical prostatectomy. Mol Urol 1999;3:201-204.
5. Meyer F, More L, Bairati I, Lacombe L, Tetu B, Fradet Y. Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific androgen failure. J Urol 1999;162:2024-2028.
6. Fair WR, Scher HI. Neoadjuvant hormonal therapy plus surgery for prostate cancer: the MSKCC experience. Surg Oncol Clin N Am 1997;6:831-846.
7. Meyer F, Bairati I, Bedard C, Lacombe L, Tetu B, Fradet Y. Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer. Urology 2001;58(2 suppl 1): S71-S77.
8. Klotz L, Gleave M, Goldenberg SL. Neoadjuvant hormone therapy: the Canadian trials. Mol Urol 2000;4:233-237; discussion, 239.
9. Schulman CC, Sassine AM. Neoadjuvant hormonal deprivation before radical prostatectomy. Eur Urol 1994;25:247.
10. Sassine AM, Schulman CC. Neoadjuvant hormonal deprivation before radical prostatectomy. Eur Urol 1993;24(Suppl 2):S46-S50.
11. Van Poppel H, Ameye F, Oyen R, Van DeVoorde W, Baert L. Neoadjuvant hormonotherapy does not facilitate radical prostatectomy. Acta Urol Belg 1992;60:73-82.
12. Guillonneau B, Vallancien G. Laparoscopic radical prostatectomy: the Montsouris technique. J Urol 2000;163:1643-1649.
13. Branstedt S, Busch C, Hellstrom M, Nordin B, Haggman M. Neoadjuvant GnRH therapy and radical prostatectomy: effects on tumorous and benign tissue volumes - a morphometric study. Urol Res 1997;25:43-47.